文献速递肝胆胰外科胃肠外科围术期管理与 ERAS

腹腔镜入路在结直肠癌肝转移二期肝切除术中的作用:单中心经验

The role of the laparoscopic approach in two-stage hepatectomy for colorectal liver metastases: a single-center experience.
PubMed 文献 · Surg Endosc · 2021-02-03

单中心回顾性研究评估腹腔镜肝切除在结直肠癌肝转移二期肝切除术中的角色,2011年9月至2020年5月共23例计划行二期肝切除术。第一期肝切除中22例(96%)腹腔镜完成无需中转,R0切除18例(78%);第二期14例(61%)完成,其中7例(50%)腹腔镜完成,中转1例(14%)。结论认为腹腔镜在二期肝切除中优势已获证实,第二期解剖性大范围肝切除在有经验者手中可行但应限于选择病例和专家中心。

要点

  • 第一期肝切除腹腔镜完成率96%,R0切除率78%,无中转。
  • 第二期肝切除仅61%患者完成,腹腔镜占50%,中转率14%。
  • 腹腔镜第二期住院时间较开腹组短3天,但失血量略高。

核心结论

  • 腹腔镜肝切除在结直肠癌肝转移二期肝切除术中已证实的优势支持其应用。
  • 第一期小范围或技术性大范围肝切除中,腹腔镜正逐渐成为金标准。
  • 第二期解剖性大范围肝切除腹腔镜可行,但应限于选择病例和专家中心。

研究设计与样本

  • 单中心回顾性研究,评估腹腔镜肝切除在二期肝切除术第一和第二期中的作用。
  • 2011年9月至2020年5月,23例患者计划行二期肝切除术。
  • 评估人口学数据、合并症因素、围手术期结局和短期结局。

主要发现

  • 第一期肝切除腹腔镜完成22例(96%),无中转,中位失血量50 cc(IQR 30-100 cc),中位术后住院4天(IQR 2.5-5天)。
  • 第一期R0切除18例(78%),其余为R1血管切除(22%)。
  • 第二期肝切除完成14例(61%),均为解剖性大范围肝切除,腹腔镜完成7例(50%),中转1例(14%)。
  • 第二期中位失血量开腹组200 cc(IQR 110-375 cc)略低于腹腔镜组240 cc(IQR 150-400 cc)。
  • 第二期中位术后住院腹腔镜组4天(IQR 3.5-4天)较开腹组7天(IQR 4.5-8.5天)短3天。

临床怎么用

  • 第一期肝切除可优先考虑腹腔镜入路,尤其小范围或技术性大范围切除。
  • 第二期解剖性大范围肝切除腹腔镜应严格选择病例,并在专家中心由有经验术者实施。

局限性

  • 单中心回顾性研究,样本量小(23例计划行二期肝切除术)。
  • 第二期肝切除仅14例完成,腹腔镜组仅7例,比较结果需谨慎解读。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: In selected patients, laparoscopic liver surgery for the treatment of colorectal liver metastases (CRLM) leads to better short-term outcomes and comparable oncologic outcomes in comparison with an open approach. However, its role in two-stage hepatectomy (TSH) remains poorly explored. METHODS: A single-center retrospective study was performed to evaluate the role of laparoscopic liver resection (LLR) in the first and second stage of TSH. Demographic data, comorbid factors, perioperative outcomes, and short-term outcomes were evaluated. RESULTS: Between September 2011 and May 2020, 23 patients were planned to undergo a TSH. The first stage hepatectomy (FSH) was performed laparoscopically in 22 patients (96%) without need for conversion. The median blood loss was 50 cc (IQR 30-100 cc) and postoperative length of hospital stay was 4 days (IQR 2.5-5 days). R0 resections were obtained in 18 FSHs (78%), while all others were R1 vascular (22%). Fourteen patients (61%) underwent a second stage hepatectomy (SSH). All SSHs were anatomically major hepatectomies. SSH was performed laparoscopically in 7 patients (50%), with need for conversion in 1 case (14%). The median blood loss was slightly lower in the open liver resection (OLR) group compared to the LLR group (200 cc (IQR 110-375 cc) vs. 240 cc (IQR 150-400 cc), respectively. The median postoperative length of hospital stay was 3 days shorter in the LLR group compared to the OLR group (4 days (IQR 3.5-4 days) vs. 7 days (IQR 4.5-8.5 days), respectively). CONCLUSIONS: The already proven advantages of LLR in the treatment of CRLM favor the role of a laparoscopic approach in TSH for CRLM. In first stage minor or technically major hepatectomy, LLR is progressively becoming the gold standard. Laparoscopic second stage anatomically major hepatectomy is feasible in experienced hands, but should be limited to selected cases and should be performed in expert centers.

来源:Surg Endosc,查看原文。版权归原作者所有。

引用

  1. Taillieu E, De Meyere C, D'Hondt M, et al. The role of the laparoscopic approach in two-stage hepatectomy for colorectal liver metastases: a single-center experience. Surg Endosc. 2021. PMID: 33537846. doi:10.1007/s00464-021-08317-0

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。